elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q52562217-0D75750C-CFEB-44DE-A629-CBC0D1685565
Q52562217-0D75750C-CFEB-44DE-A629-CBC0D1685565
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52562217-0D75750C-CFEB-44DE-A629-CBC0D1685565
Fostamatinib for the Treatment of Adult Persistent and Chronic Immune Thrombocytopenia: Results of Two Phase 3, Randomized, Placebo-Controlled Trials.
P2860
Q52562217-0D75750C-CFEB-44DE-A629-CBC0D1685565
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52562217-0D75750C-CFEB-44DE-A629-CBC0D1685565
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5e17ad9ff810aad09767a043571b9d5da5dbfa06
P2860
OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapy